Natural Product Sciences

The Korean Society of Pharmacognosy (한국생약학회)
권호 표지

Molecular Mechanisms of Regulation of Human Cytochrome P4501A2 Gene Expression

  • Published : 2004.10.30
Download PDF
⟨ Previous Next ⟩

Abstract

Cytochrome P4501A2 (CYP1A2) is responsible for the metabolic activation of a number of aromatic amines and amides to mutagenic and carcinogenic moieties. Considerable variations in the level of CYP1A2 expression in humans have been reported. Thus, the level of human CYP1A2 may determine an individuals susceptibility to these chemicals. Given its importance, the molecular mechanisms of CYP1A2 regulation have been studied by many groups. Direct interactions between transcription factors with the promoters of the gene represent one of the primary means by which the expression of CYP1A2 is controlled. In this review, several important cis elements, transcription factors and the effects of deacetylation/methylation of promoter regions that play an important role in the induction by PAHs as well as constitutive expression of human CYP1A2 are discussed.

Keywords

References

  1. Aitchison, K.J., Gonzalez, F.J., Quattrochi, L.C., Sapone, A., Zhao, J.H., Zaher, H., Elizondo, G., Bryant, C., Munro, J., Collier, D.A., Makoffa, A.I., and Kerwin, R.W., Identification of novel polymorphisms in the 5' flanking region of CYP1A2, characterization of interethnic variability, and investigation of their functional significance. Phannacogenetics 10(8), 695-704 (2000) https://doi.org/10.1097/00008571-200011000-00004
  2. Angel, P. and K-arin, M., The role of Jun, Fos and the AP-l complex in cell-proliferation and transformation. Biochim. Biophys. Acta. 1072(2-3), 129-157 (1991)
  3. Aoyama, T., Gonzalez, F.J. and Gelboin, H.V., Human cDNA-expressed cytochrome P450IA2: mutagen activation and substrate specificity. Mol. Carcinog. 2(4), 192-198 (1989) https://doi.org/10.1002/mc.2940020405
  4. Barnett, C.R., Wilson, J., Wolf, C.R., Ratt, P.R., and loannides, C., Hyperinsulinaemia causes a preferential increase in hepatic P4501A2 activity. Biochem. Phai-macol. 43(6), 1255-1261 (1992) https://doi.org/10.1016/0006-2952(92)90500-I
  5. Burbach, K.M., Poland, A., and Bradfild, C.A., Cloning of the Ah-receptor cDNA reveals a distinctive ligand-activated transcription factor. Proc. Natl. Acad. Sci. U.S.A. 89(17), 8185-8189 (1992) https://doi.org/10.1073/pnas.89.17.8185
  6. Butler, M.A., Iwasaki, M., Guengerich, F.P, and Kadlubar, F.R, Human cytochrome P-450PA (P-450IA2), the phenacetin 0 deethylase, is primarily responsible for the hepatic 3-demethylation of caffeine and N-oxidation of carcinogenic arylamines. Proc. Natl. Acad. Sci. U.S.A. 86(20), 7696-7700 (1989) https://doi.org/10.1073/pnas.86.20.7696
  7. Cheung, C., Akiyama, T.E., Kudo, G., and Gonzalez, F.J., Hepaticexpression of cytochrome P450s in hepatocyte nuclear factor l-alpha (HNFlalpha)-deficient mice. Biochem. Pharmacol. 66(10), 2011-2020 (2003) https://doi.org/10.1016/S0006-2952(03)00586-0
  8. Chung, I. and Bresnick, E., 3-Methylcholanthrene-mediated induction of cytochrome P4501A2 in human hepatoma HepG2 cells as quantified by the reverse transcnption-polymerase chain reaction. Arch. Biochem. Biophys. 314(1), 75-81 (1994) https://doi.org/10.1006/abbi.1994.1413
  9. Chung, I. and Bresnick, E., Regulation of the constitutive expression of human CYP1A2 gene: cis elements and their interactions with proteins. Mol. Pharmacol. 47, 677-685 (1995)
  10. Chung, I. and Bresnick, E., Identification of positive and negative regulatory elements of the human cytochrome P4501A2 (CYP1A2) gene. Arch. Biochem. Biophys. 338(2), 220-226 (1997) https://doi.org/10.1006/abbi.1996.9815
  11. Chung, I., Human CYP1A2 promoter fused-luciferase gene constructs hardly respond to polycyclic hydrocarbons in tansient transfection study in HepG2 cells. Journal. of Toxi cology and Public Health 16(2), 95-100 (2000)
  12. Chung, I. and Jung, K., No role of Protected Region B of Human Cytochrome P4501A2 Gene (CYP1A2) As an AP-l Response Element. Arch. Pharm. Res. 25(3), 375-380 (2002) https://doi.org/10.1007/BF02976642
  13. Corchero, J., Pimprale, S., Kimura, S., and Gonzalez, F.J., Organization of the CYP1A cluster on human chromosome 15: implications for gene regulation. Pharmacogenetics 11(1), 1-6 (2001) https://doi.org/10.1097/00008571-200102000-00001
  14. Diaz, D., Fabre, I., Daujat, M., Saint Aubert, B., Bories, R., Michel, H., and Maurel, R, Omeprazole is an aryl hy drocarbon-like inducer of human hepatic cytochrome P450. Gastroenterology 99(3), 737-747 (1990) https://doi.org/10.1016/0016-5085(90)90963-2
  15. Ding, X.X., Koop, D.R., Cmmp, B.L., and Coon, M.J., Immunochemical identification of cytochrome P-450 isozyme 3a (P-450ALC) in rabbit nasal and kidney microsomes andevidence for differential induction by alcohol. Mol. Pharmacol.30(4), 370-378 (1986)
  16. Ding., X.X. and Coon, M.J., Immunochemical characterization of multiple forms of cytochrome P-450 in rabbit nasal microsomes and evidence for tissue-specific expression of P-450s NMa and NMb. Mol. Pharmacol. 37(4), 489-496 (1990)
  17. Gillner, M., Brittebo, E.B., Brandt, I., Soderkvist, R, Appelgren, L.E., and Gustafsson, J.A., Uptake and specific binding of 2,3,7,8-tetrach1orodibenzo-p-dioxin in the olfactory mucosa of mice and rats. Cancer Res. 47(15), 4150-4159 (1987)
  18. Gonzalez, F.J., Tukey, R.H. and Nebert, D.W., Stmctural gene products of the Ah locus. Transcriptional regulation of cytochrome P1-450 and P3-450 mRNA levels by 3-methylcholanthrene. Mol. Pharmacol. 26(1), 117-121 (1984)
  19. Gonzalez, FJ. and Nebert, D.W,, Evoludon of the P450 gene superfamily: animal-plant 'warfare', molecular drive and human genetic differences in drug oxidation. Trends Genet. 6(6), 182-186(1990) https://doi.org/10.1016/0168-9525(90)90174-5
  20. Gonzalez, F.J. and Gelboin, H.V, Role of human cytochrome P-450s in risk assessment and susceptibility to environmentally based disease. J. Toxicol. Environ. Heatth 40(2-3), 289-308 (1993) https://doi.org/10.1080/15287399309531795
  21. Gonzalez, F.J. and Kimura, S., Study of P450 function using gene knockout and transgenic mice. Arch. Biochem. Biophys. 409(1), 153-158 (2003) https://doi.org/10.1016/S0003-9861(02)00364-8
  22. Hakkola, J., Raunio, H., Purkunen, R., Pelkonen, O., Saahkoski, S., Cresteil, T, and Pasanen, M., Detection of cytochrome P450 gene expression in human placenta in first trimester of pregnancy. Biochem. Pharmacol. 52(2), 379-383 (1996) https://doi.org/10.1016/0006-2952(96)00216-X
  23. Hammons, G.J., Yan-Sanders, Y, Jin, B., Blann, E., Kadlubar, P.R, and Lyn-Cook, B.D., Specific site methylation in the 5'-flanking region of CYP1A2 intel-individual differences in human livers. Life Sci. 69(7), 839-845 (2001) https://doi.org/10.1016/S0024-3205(01)01175-4
  24. Horbach, G.J., Van Asten, J.G., and Van Bezooijen, C.R, The influence of age on the inducibility of rat liver cytochrome P450IA1 (CYPIAl) and P450IA2 (CYPIA2) mRNAs. Mutat. Res. 237(3-4), 117-121 (1990) https://doi.org/10.1016/0921-8734(90)90017-L
  25. Ilett, K.R, Casdeden, W.M., Vandongen, Y.K., Stacey, M.C., Butler, M.A., and Kadlubar, F.F., Acetylation phenotype and cytochrome P450IA2 phenotype are unlikely to be associated with peripheral arterial disease. Clin. Pharmacol. Ther. 54(3), 317-322 (1993) https://doi.org/10.1038/clpt.1993.153
  26. Imaoka, S., Terano, Y., and Funae, Y, Changes in the amount of cytochrome P450s in rat hepatic microsomes with starvation. Arch. Biochem. Biophys. 278(1), 168-177 (1990) https://doi.org/10.1016/0003-9861(90)90245-T
  27. Imbra, R.J. and Kahn, M., Metallothionem gene expression is regulated by serum factors and activators of protein kinase C. Mol. Cell. Biol. 7(4), 1358-1363 (1987) https://doi.org/10.1128/MCB.7.4.1358
  28. Fisher, J.M., Wu, L., Denison, M.S., and Whitlock, Jr. J.R., Organization and function of a dioxin-responsive enhancer. J. Bio. Chem. 265, 9676-9681 (1990)
  29. Hoffman, E.C., Reyes, H., Chu, F.R, Sander, R, Conley, L.H., Brooks, B.A., and Hankinson, O., Cloning of a factor required for activity of the Ah (dioxin) receptor. Science 252(5008), 954-958 (1991) https://doi.org/10.1126/science.1852076
  30. Kalow, W. and Tang, B.K., Use of caffeine metabolite rados to explore CYP1A2 and xanthine oxidase activities. Clin. Pharmacol. Ther. 50(5) Pt 1, 508-519 (1991) https://doi.org/10.1038/clpt.1991.176
  31. Kimura, S., Gonzalez, F.J., and Nebert, D.W., Tissue specific expression of the mouse dioxin inducible P( 1)450 and P(3)450 genes: differential transcriptional activadon and mRNA stability in liver and extrahepatic tissues. Mol. Cell. Biol. 6(5), 1471-1477 (1986) https://doi.org/10.1128/MCB.6.5.1471
  32. Kimura, S., Kawabe, M., Yu, A., and others, Carcinogenesis of the food mutagen PhIP in mice is independent of CYP1A2. Carcinogenesis 24(3), 583-587 (2003) https://doi.org/10.1093/carcin/24.3.583
  33. Kokwaro, G.O., Glazier, A.R, Ward, S.A., Breckenridge, A.M., and Edwards, G., Effect of malaria infection and endotoxin-induced fever on phenacetin O-deethylation by rat liver microsomes. Biochem. Pharmacol. 45(6), 1235-1241 (1993)
  34. Koser, P.L., Faletto, M.B., Maccubbin, A.E., and Gurtoo, H.L., The genetics of aflatoxin Bl metabolism. Association of the induction of aflatoxin Bl-4-hydroxylase with the tran-sc riptional activation of cytochrome P3-450 gene. J. Biol. Chem. 263(25), 12584-12595 (1988)
  35. Lamph, W.W., Wamsley, R, Sassone-Corsi, P., and Venna, I.M., Induction of proto-oncogene JUN/AP-l by semm and TPA. Nature 334(6183), 629-631 (1988) https://doi.org/10.1038/334629a0
  36. Landers, J.P. and Bunce, N.J., The Ah receptor and the mechanism of dioxin toxicity. Biohem. J. 276(Pt 2), 273-287 (1991)
  37. Lee, W., Mitchel.l R, and Tjian, R., Purified transcnption factor AP-l interacts with TPA-inducible enhancer elements. Cell 49(6), 741-752 (1987) https://doi.org/10.1016/0092-8674(87)90612-X
  38. Lin, L., Yang, R, Ye, Z., Xu, E., Yang, C., Zhang, C., Wu, D., and Nebert, D.W., Case-control study of cigarette smoking and primary hepatoma in an aflatoxin-endemic region of China: a protective effect. Pharmacogenetics 1(2), 79-85 (1991) https://doi.org/10.1097/00008571-199111000-00004
  39. Murata, M., Watanabe, M., Yamanaka, M., Kubota, Y, Ito, H.,Nagao, M., Katoh, T., Kamataki, T, Kawamura, J., Yatani, R.,and Shiraishi, T., Genetic polymorphisms in cytochrome P450(CYP) 1A1, CYP1A2, CYP2E1, glutathione S-transferase(GST) Ml and GSTTl and susceptibility to prostate cancer inthe Japanese population. Cancer Letters 165(2), 171-177(2001) https://doi.org/10.1016/S0304-3835(01)00398-6
  40. Murata, M., Watanabe, M., Yamanaka, M., Kubota,Y, Ito, H.,Nagao, M., Katoh, T., Kamataki, T, Kawamura, J., Yatani, R.,and Shiraishi, T, Genetic polymorphisms in cytochrome P450(CYP) 1A1, CYP1A2, CYP2E1, glutathione S-transferase (GST)Ml and GSTTl and susceptibility to prostate cancer in theJapanese population. Cancer Letters 165(2), 171-177 (2001) https://doi.org/10.1016/S0304-3835(01)00398-6
  41. Massari, M.E. and Murre, C., Helix-loop-helix proteins: re gulators of transcription in eucaryotic organisms. Mol. Cell Biol. 20(2), 429-440 (2000) https://doi.org/10.1128/MCB.20.2.429-440.2000
  42. McKinnon, R.A., Hall, P.D., Quattrochi, L.C., Tukey, R.H., and McManus, M.E., Localization of CYP1A1 and CYP1A2 messenger RNA in normat human liver and in hepatocellular carcinoma by in situ hybridization. Hepatotogy 14(5), 848-856 (1991)
  43. Mendel, D.B. and Crabtree, G.R., HNF-l, a member of a novelclass of dimerizing homeodomain proteins. J. Biol. Chem 266(2), 677-680 (1991)
  44. Morville, A.L., Thomas, R, Levin, W., Reik, L., Ryan, D.E., Raphael, C., and Adesnik, M., The accumulation of distinct mRNAs for the immunochemically related cytochromes P-450c and P-450d in rat liver following 3-methylcholanthrene treatment. J. Biol. Chem. 258(6), 3901-3906 (1983)
  45. Nakajima, M., Yokoi, T., Mizutani, M., Kinoshita, M., Funayama, M., and Kamataki, T., Genetic polymorphism in the 5'-flanking region of human CYP1A2 gene: effect on the CYP1A2 inducibility in humans. J. Biochem. (Tokyo) 125(4), 803-808 (1999) https://doi.org/10.1093/oxfordjournals.jbchem.a022352
  46. Nakajima, M., Iwanari, M., and Yokoi, T., Effects of histone deacetylation and DNA methylation on the constitutive and TCDD-inducible expressions of the human CYPl family in MCF-7 and HeLa cells. Toxicol. Lett. 144(2), 247-256 (2003) https://doi.org/10.1016/S0378-4274(03)00216-9
  47. Nebert, D.W. and Jones, J.E., Regulation of the mammalian cytochrome P1-450 (CYP1A1) gene. Int. J. Biochem. 21(3), 243-52 (1989) https://doi.org/10.1016/0020-711X(89)90182-1
  48. Nelson, D.R., Zeldin, D.C., Hoffman, S.M., Maltais, L.J., Wain, H.M., and Nebert, D.W., Comparison of cytochrome P450 (CYP) genes from the mouse and human genomes, including nomenclature recommendations for genes, Pseudogenes and alternative-splice variants. Pharmacogenetics 14(1), 1-18 (2004) https://doi.org/10.1097/00008571-200401000-00001
  49. Nemoto, N. and Sakurai, J., Activation of Cyplal and Cyp1a2 genes in adult mouse hepatocytes in primary culture. Jpn. J. Cancer. Res. 84(3), 272-278 (1993) https://doi.org/10.1111/j.1349-7006.1993.tb02867.x
  50. Okino, S.T., Pendurthi, U.R., and Tukey, R.H., Phorbol esters inhibit the dioxin receptor-mediated transcriptional activation of the mouse Cypla-l and Cyp1a-2 genes by 2,3,7,8-tetrachlorodibenzo-p-dioxin. J. Biol. Chem. 267(10), 6991-6998 (1992)
  51. Padgham, C.R., Paine, A.J., Phillips, I.R., and Shephard, E.A., Maintenance of total cytochrome P-450 content in rat hepatocyte culture and the abundance of CYP1A2 and CYP2B1/2 mRNAs. Biochem. J. 285(Pt3), 929-932 (1992) https://doi.org/10.1042/bj2850929
  52. Pasanen, M., Haaparanta, T, Sundin, M., Sivonen, R, Vakakangas, K., Raunio, H., Hines, R., Gustafsson, J.A., and Pelkonen, O., Immunochemical and molecular biological studies on human placental cigarette smoke-inducible cytochrome P-450-dependent monooxygenase activities. Toxicotogy 62(2), 175-187 (1990)
  53. Pasco, D.S., Boyum, K.W., Merchant, S.N., Chalberg, S.C., and Pagan, J.B., Transcriptional and post-transcriptional regulation of the genes encoding cytochromes P-450c and P-450d in vivo and in primary hepatocyte cultures. J. Biol. Chem. 263(18), 8671-8676 (1988)
  54. Pasco, D.S., Boyum, K.W., Elbi, C., Siu, C.S., and Fagan, J.B., Inducer-dependent transcriptional activation of the P4501A2 gene in vivo and in isolated hepatocytes. J. Biol. Chem. 268(2), 1053-7 (1993)
  55. Pickwell, G.V., Shih, H., and Quattrochi, L.C., Interaction of upstream stimulatory factor proteins with an E-box located within the human CYP1A2 S'-tlanking gene contributes tobasal transcriptional gene activation. Biochem. Pharmacol. 65(7), 1087-1096 (2003) https://doi.org/10.1016/S0006-2952(03)00037-6
  56. Pineau, T., Daujat, M., Pichard, L., Girard, F, Angevain, J., Bonfils, C., and Maurel, P., Developmental expression of rabbit cytochrome P450 CYP1A1, CYP1A2 and CYP3A6 genes. Effect of weaning and nfampicin. Eur. J. Biochem. 197(1), 145-153 (1991) https://doi.org/10.1111/j.1432-1033.1991.tb15893.x
  57. Postlind, H., Vu, T.R, Tukey, R.H., and Quattrochi, L.C., Response of human CYPl-luciferase plasmids to 2,3,7,8-tetrach1orodibenzo-p-dioxin and polycyclic aromatic hydrocarbons. Toxicol. Appl. Phannacol. 118, 255-262 (1993) https://doi.org/10.1006/taap.1993.1031
  58. Quattrochi, L.Q, Vu, T., and Tukey, R.H., The human CYP1A2 gene and induction by 3-methylcholanthrene. J. Biol. Chem. 269, 6949-6954 (1994)
  59. Quattrochi, L.C., Shih, H., and Pickwell, G.V., Induction of the human CYP1A2 enhancer by phorbol ester. Arch. Biochem. Biophys. 350(1), 41-48 (1998) https://doi.org/10.1006/abbi.1997.0491
  60. Raha, A., Reddy, V, Houser, W.H., and Bresnick, E., Binding characteristics of 4S PAH-binding proteins and Ah receptor from rats and mice. J. Toxicol. Environ. Health 29, 339-355 (1990) https://doi.org/10.1080/15287399009531397
  61. Raha, A., Wagner, C., McDonald, R.G., and Bresnick, E., Rat liver cytosolic 4S polycylic aromatic hydrocarbon (PAH)-binding protein is glycine N-methyltransferase. J. Biol. Chem. 269, 5750-575 (1994)
  62. Raha, A., Joyce, T, Gusky, S., and Bresnick, E., Glycine N-methyltransferase is a mediator of cytochrome P4501A1 gene expression. Arch. Biochem. Biophys. 322, 395-404 (1995) https://doi.org/10.1006/abbi.1995.1480
  63. Ratanasavanh, D., Beaune, R, Morel, R, Flinois, J.R, Guengerich, F.R, and Guillouzo, A,, Intralobular distribution and quantitation of cytochrome P-450 enzymes in human liver as a function of age. Hepatotogy 13(6), 1142-1151 (1991)
  64. Raval, R, Iversen, P.L., and Bresnick, E., Induction of cytochromes P450IA1 and P450IA2 as determined by solution hybhdization. Biochem. Pharmacol, 41(11), 1719-1723 (1991) https://doi.org/10.1016/0006-2952(91)90175-5
  65. Relling, M.V, Lin, J.S., Ayers, G.D., and Evans, W.E., Racial and gender differences in N-acetyltransferase, xanthine oxidase, and CYP1A2 activities. Ctin. Pharmacol. Ther. 52(6), 643-658 (1992) https://doi.org/10.1038/clpt.1992.203
  66. Reyes, H., Reisz-Porszasz, S., and Hankinson, O., Identification of the Ah receptor nuclear translocator protein (Amt) as a component of the DNA binding form of the Ah receptor. Science 256(5060), 1193-1195 (1992) https://doi.org/10.1126/science.256.5060.1193
  67. Sachse, C., Brockmoller, J., Bauer, S., and Roots, I., Functional signiScance of a C-->A polymorphism in intron 1 of the cytochrome P450 CYP1A2 gene tested with caffeine. Br. J. Ctin. Pharmacol. 47(4), 445-449 (1999) https://doi.org/10.1046/j.1365-2125.1999.00898.x
  68. Schweikl, H., Taylor, J.A., Kitareewan, S., Linko, R, Nagomey, D., and Goldstein, J.A., Expression of CYP1A1 and CYP1A2 genes in human liver. Pharmacogenetics 3(5), 239-249 (1993) https://doi.org/10.1097/00008571-199310000-00003
  69. Sesardic, D., Boobis, A.R., Edwards, R.J., and Davies, D.S., A form of cytochrome P450 in man, orthologous to form d in the rat, catalyses the O-deethylation of phenacetin and is inducible by cigarette smoking. Br. J. Clin. Pharmacol. 26(4), 363-372(1988) https://doi.org/10.1111/j.1365-2125.1988.tb03393.x
  70. Sesardic, D., Pasanen, M., Pelkonen, O., and Boobis, A.R., Differential expression and regulation of members of the cy tochrome P450IA gene subfamily in human tissues. Ca rcinogenesis 11(7), 1183-1188 (1990)
  71. Sherson, D., Sigsgaard, T., Overgaard, E., Loft, S., Poulsen, H.E., and Jongeneelen, F.J., Interaction of smoking, uptake of polycyclic aromatic hydrocarbons, and cytochrome P450IA2 activity among foundry workers. Br. J. Ind. Med. 49(3), 197-202 (1992)
  72. Siegfried, Z., and Cedar, H., DNA methylation: a molecular lock. Curr. Biol. 7(5), R305-307 (1997) https://doi.org/10.1016/S0960-9822(06)00144-8
  73. Silver, G. and Krauter, K.S., Expression of cytochromes P-450c and P-450d mRNAs in cultured rat hepatocytes. 3-Me thylcholanthrene induction is regulated primarily at the post-transcriptional level. J. Biol. Chem. 263(24), 11802-11807(1988)
  74. Silver, G, and Krauter, K.S., Aryl hydrocarbon induction of ratcytochrome P-450d results from increased precursor RNAprocessing. Mol Cell. Biol. 10(12), 6765-8 (1990) https://doi.org/10.1128/MCB.10.12.6765
  75. Sinclair, P.R., Bement, W.J., Lambrecht, R.W., Gorman, N., and Sinclair, J.R, Chlorinated biphenyls induce cytochrome P450IA2 and uroporphyrin accumulation in cultures of mouse hepatocytes. Arch. Biochem. Biophys. 281(2), 225-232 (1990) https://doi.org/10.1016/0003-9861(90)90436-3
  76. noassay detects cytochrome P-450 in human placenta and lymphocytes. Science 228(4698), 490-492 (1985) https://doi.org/10.1126/science.2580351
  77. Sterling, K., Raha, A., and Bresnick, E., Induction of CYP1A1 gene expression in mouse hepatoma cells by benzo[e]Pyrene, a ligand of the 4S polycyclic hydrocarbon-binding protein.Toxicol. Appl. Pharmacol. 128(1), 18-24 (1994) https://doi.org/10.1006/taap.1994.1175
  78. Suzuki, T., Okuno, H., Yoshida, T., Endo, T., Nishina, H., and Iba, H., Difference in transcriptional regulatory function between c-Fos and Fra-2. Nucleic Acids Res. 19(20), 5537-5542 (1991) https://doi.org/10.1093/nar/19.20.5537
  79. Thomas, P.E., Reik, L.M., Ryan, D.E., and Levin, W., Induction of two immunochemically related rat liver cytochrome P-450 isozymes, cytochromes P-450c and P-450d, by structurally diverse xenobiotics. J. Biol. Chem. 258(7), 4590-4598 (1983)
  80. Tronche, F. and Yaniv, M., HNFl, a homeoprotein member of the hepatic transcription regulatory network. Bioessays 14(9), 579-587 (1992) https://doi.org/10.1002/bies.950140902
  81. Tuteja, N., Gonzalez, F.J., and Nebert, D.W., Developmental and tissue-speciSc differential regulation of the mouse dioxin-in ducible P1-450 and P3-450 genes. Dev. Biol. 112(1), 177-184 (1985) https://doi.org/10.1016/0012-1606(85)90131-9
  82. Vistisen, K., Poulsen, H.E., and Loft, S., Foreign compound metabolism capacity in man measured from metabolites of dietary caffeine. Carcinogenesis 13(9), 1561-1568 (1992) https://doi.org/10.1093/carcin/13.9.1561
  83. Wei, C., Caccavale, R.J., Kehoe, J.J., Thomas, P.E., and Iba, M.M., CYP1A2 is expressed along with CYP1A1 in the human lung. Cancer Lett. 171(1), 113-120 (2001) https://doi.org/10.1016/S0304-3835(01)00529-8
  84. Whitlock, J.P. Jr., Genetic and molecular aspects of 2,3,7,8-tetrachlorodibenzo-p-dioxin action. Annu. Rev. Pharmacol. Toxicol. 30, 251-277 (1990) https://doi.org/10.1146/annurev.pa.30.040190.001343
  85. Wrighton, S.A., Campanile, C., Thomas, P.E., Maines, S.L., Watldns, P.B., Parker, G., Mendez-Rcon, G., Haniu, M., Shively, J.E., Levin, W., and Guzelian, P.S., Identification of a human liver cytochrome P-450 homologous to the major isosafole-inducible cytochrome P-450 in the rat. Mol. Pharmacol. 29(4), 405U10 (1986)
  86. Wu, C., Chromatin remodeling and the control of gene expression. J. Biol. Chem. 272(45), 28171-28174 (1997) https://doi.org/10.1074/jbc.272.45.28171